Journal article
Pegylated Interferon Lambda for Covid-19
Abstract
To the Editor: Severe Covid-19 is characterized by interferon-λ deficiency.1 In the TOGETHER trial, Reis et al. (Feb. 9 issue)2 found notable efficacy of a single subcutaneous administration of peg...
Authors
Andreakos E; Tsiodras S
Journal
The New England Journal of Medicine, Vol. 388, No. 22, pp. 2107–2108
Publisher
Massachusetts Medical Society
Publication Date
6 2023
DOI
10.1056/nejmc2303519
ISSN
0028-4793